Pfizer to supply UNICEF up to 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-income countries
The Pharma Data
MARCH 22, 2022
Pfizer continues to invest to support the manufacturing and distribution of PAXLOVID, including exploring potential contract manufacturing options. Financial details of the agreement were not disclosed. High and upper-middle income countries will pay more than lower income countries.
52 
Let's personalize your content